Chartwell Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.8M | Buy |
17,496
+5,496
| +46% | +$3.25M | 0.37% | 73 |
|
|
2024
Q2 | $6.64M | Hold |
12,000
| – | – | 0.23% | 141 |
|
|
2024
Q1 | $6.97M | Hold |
12,000
| – | – | 0.24% | 140 |
|
|
2023
Q4 | $6.37M | Hold |
12,000
| – | – | 0.22% | 162 |
|
|
2023
Q3 | $6.07M | Hold |
12,000
| – | – | 0.24% | 162 |
|
|
2023
Q2 | $6.26M | Sell |
12,000
-6,476
| -35% | -$3.49M | 0.23% | 168 |
|
|
2023
Q1 | $10.6M | Buy |
18,476
+1,358
| +8% | +$765K | 0.4% | 76 |
|
|
2022
Q4 | $9.43M | Buy |
17,118
+1,818
| +12% | +$963K | 0.37% | 97 |
|
|
2022
Q3 | $7.76M | Hold |
15,300
| – | – | 0.33% | 110 |
|
|
2022
Q2 | $8.31M | Hold |
15,300
| – | – | 0.33% | 104 |
|
|
2022
Q1 | $9.04M | Hold |
15,300
| – | – | 0.3% | 125 |
|
|
2021
Q4 | $10.2M | Hold |
15,300
| – | – | 0.3% | 127 |
|
|
2021
Q3 | $8.74M | Hold |
15,300
| – | – | 0.27% | 139 |
|
|
2021
Q2 | $7.72M | Sell |
15,300
-3,700
| -19% | -$1.75M | 0.23% | 157 |
|
|
2021
Q1 | $8.67M | Hold |
19,000
| – | – | 0.26% | 149 |
|
|
2020
Q4 | $8.85M | Sell |
19,000
-2,000
| -10% | -$938K | 0.28% | 145 |
|
|
2020
Q3 | $9.27M | Hold |
21,000
| – | – | 0.34% | 114 |
|
|
2020
Q2 | $7.61M | Sell |
21,000
-4,000
| -16% | -$1.34M | 0.29% | 139 |
|
|
2020
Q1 | $7.09M | Sell |
25,000
-2,000
| -7% | -$631K | 0.33% | 117 |
|
|
2019
Q4 | $8.77M | Hold |
27,000
| – | – | 0.29% | 148 |
|
|
2019
Q3 | $7.86M | Hold |
27,000
| – | – | 0.26% | 157 |
|
|
2019
Q2 | $7.93M | Sell |
27,000
-2,500
| -8% | -$689K | 0.26% | 152 |
|
|
2019
Q1 | $8.07M | Sell |
29,500
-3,000
| -9% | -$747K | 0.26% | 145 |
|
|
2018
Q4 | $7.27M | Hold |
32,500
| – | – | 0.26% | 134 |
|
|
2018
Q3 | $7.93M | Sell |
32,500
-2,500
| -7% | -$575K | 0.23% | 155 |
|
|
2018
Q2 | $7.25M | Hold |
35,000
| – | – | 0.22% | 162 |
|
|
2018
Q1 | $7.23M | Hold |
35,000
| – | – | 0.25% | 150 |
|
|
2017
Q4 | $6.65M | Hold |
35,000
| – | – | 0.23% | 158 |
|
|
2017
Q3 | $6.62M | Hold |
35,000
| – | – | 0.23% | 155 |
|
|
2017
Q2 | $6.11M | Sell |
35,000
-5,000
| -13% | -$840K | 0.23% | 142 |
|
|
2017
Q1 | $6.14M | Hold |
40,000
| – | – | 0.22% | 151 |
|
|
2016
Q4 | $5.64M | Hold |
40,000
| – | – | 0.19% | 171 |
|
|
2016
Q3 | $6.36M | Hold |
40,000
| – | – | 0.11% | 224 |
|
|
2016
Q2 | $5.91M | Hold |
40,000
| – | – | 0.11% | 217 |
|
|
2016
Q1 | $5.66M | Buy |
40,000
+5,000
| +14% | +$670K | 0.11% | 187 |
|
|
2015
Q4 | $4.96M | Buy |
35,000
+2,500
| +8% | +$333K | 0.1% | 214 |
|
|
2015
Q3 | $3.97M | Buy |
32,500
+7,500
| +30% | +$977K | 0.09% | 230 |
|
|
2015
Q2 | $3.24M | Hold |
25,000
| – | – | 0.06% | 256 |
|
|
2015
Q1 | $3.36M | Sell |
25,000
-178,590
| -88% | -$23M | 0.07% | 260 |
|
|
2014
Q4 | $25.5M | Sell |
203,590
-193,060
| -49% | -$23.5M | 0.53% | 43 |
|
|
2014
Q3 | $48.3M | Sell |
396,650
-2,815
| -0.7% | -$342K | 1.09% | 4 |
|
|
2014
Q2 | $47.1M | Sell |
399,465
-1,200
| -0.3% | -$141K | 0.98% | 7 |
|
|
2014
Q1 | $48.2M | Buy |
400,665
+225,685
| +129% | +$26.8M | 0.98% | 11 |
|
|
2013
Q4 | $19.5M | Buy |
174,980
+155,135
| +782% | +$15.4M | 0.4% | 89 |
|
|
2013
Q3 | $1.83M | Buy |
19,845
+5,075
| +34% | +$459K | 0.04% | 306 |
|
|
2013
Q2 | $1.25M | Buy |
+14,770
| New | +$1.23M | 0.03% | 310 |
|
Other funds holding TMO
Chartwell Investment Partners's TMO Position: Q3 2024 in Review
Chartwell Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 46% in Q3 2024, buying an estimated $3.25M and bringing the position to 17,496 shares worth $10.8M. The position accounts for 0.37% of the portfolio, ranked #73.
Chartwell Investment Partners first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. The position peaked at $48.3M in Q3 2014. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.
- Chartwell Investment Partners held 17,496 shares of Thermo Fisher Scientific worth $10.8M as of Q3 2024.
- Chartwell Investment Partners bought 5,496 Thermo Fisher Scientific shares in Q3 2024, an estimated $3.25M.
- Thermo Fisher Scientific made up 0.37% of Chartwell Investment Partners's portfolio in Q3 2024, its #73 holding.
- Chartwell Investment Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
- Chartwell Investment Partners's Thermo Fisher Scientific position peaked at $48.3M in Q3 2014.
- 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.
Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.